MedTrace Logo

Post-Market Clinical Follow Up of Rotarex®S Catheter

NCT04010123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2023-02-09

No results posted yet for this study

Summary

Post-Market Clinical Follow Up of the Rotarex®S Catheter

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Atherectomy/Thrombectomy

Percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels in native blood vessels or vessels fitted with stents, stent grafts or native or artificial bypasses.

Sponsors & Collaborators

  • Straub Medical AG

    lead INDUSTRY

Principal Investigators

  • Michael Lichtenberg, Dr. med. · Klinikum Hochsauerland GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-17
Primary Completion
2022-10-26
Completion
2022-10-26

Countries

  • Czechia
  • Estonia
  • France
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010123 on ClinicalTrials.gov